View Past PerformanceCyient バランスシートの健全性財務の健全性 基準チェック /66Cyientの総株主資本は₹61.6B 、総負債は₹2.0Bで、負債比率は3.2%となります。総資産と総負債はそれぞれ₹83.2Bと₹21.6Bです。 Cyientの EBIT は₹6.6Bで、利息カバレッジ比率-25.2です。現金および短期投資は₹16.7Bです。主要情報3.22%負債資本比率₹1.99b負債インタレスト・カバレッジ・レシオ-25.2x現金₹16.68bエクイティ₹61.63b負債合計₹21.61b総資産₹83.24b財務の健全性に関する最新情報分析記事 • Aug 21Here's Why Cyient (NSE:CYIENT) Can Manage Its Debt ResponsiblyNSEI:CYIENT 1 Year Share Price vs Fair Value Explore Cyient's Fair Values from the Community and select yours Some say...分析記事 • Feb 08Cyient (NSE:CYIENT) Has A Pretty Healthy Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...分析記事 • Aug 19Cyient (NSE:CYIENT) Seems To Use Debt Rather SparinglySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...分析記事 • Mar 04Is Cyient (NSE:CYIENT) A Risky Investment?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...すべての更新を表示Recent updatesBuy Or Sell Opportunity • Jul 09Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.7% to ₹831. The fair value is estimated to be ₹1,039, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.7% over the last 3 years. Earnings per share has declined by 4.8%. For the next 3 years, revenue is forecast to grow by 11% per annum. Earnings are also forecast to grow by 22% per annum over the same time period.Reported Earnings • Jun 13Full year 2026 earnings: EPS and revenues miss analyst expectationsFull year 2026 results: EPS: ₹38.78 (down from ₹55.95 in FY 2025). Revenue: ₹72.7b (down 1.3% from FY 2025). Net income: ₹4.28b (down 31% from FY 2025). Profit margin: 5.9% (down from 8.4% in FY 2025). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) also missed analyst estimates by 27%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.お知らせ • Jun 10+ 5 more updatesCyient Limited Proposes Not to Pay Final Dividend for the Year Ended on March 31, 2026Cyient Limited proposed Final dividend for the year ended on March 31, 2026: Nil (March 31, 2025: INR 14 per share).お知らせ • Jun 01Cyient Limited (BSE:532175) agreed to acquire Tao Digital Solutions Inc.Cyient Limited (BSE:532175) agreed to acquire Tao Digital Solutions Inc. on May 30, 2026. The transaction implies an enterprise value of $218 million, excluding management incentives, and retention schemes. The nature of consideration is in cash, including upfront payment and performance-linked earnout. For the period ending December 31, 2025, Tao Digital Solutions Inc. reported total revenue of $79.1 million. The transaction is subject to approval by regulatory board / committee. The expected completion of the transaction is on or before September 30, 2026.分析記事 • May 01Cyient's (NSE:CYIENT) Soft Earnings Are Actually Better Than They AppearInvestors were disappointed with the weak earnings posted by Cyient Limited ( NSE:CYIENT ). However, our analysis...Reported Earnings • Apr 29Full year 2026 earnings: EPS and revenues miss analyst expectationsFull year 2026 results: EPS: ₹38.78 (down from ₹55.95 in FY 2025). Revenue: ₹72.7b (down 1.3% from FY 2025). Net income: ₹4.28b (down 31% from FY 2025). Profit margin: 5.9% (down from 8.4% in FY 2025). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) also missed analyst estimates by 27%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 10% per year.お知らせ • Apr 24Cyient Limited (BSE:532175) announces an Equity Buyback for 6,400,000 shares, for INR 7,200 million.Cyient Limited (BSE:532175) announces a share repurchase program. Under the program, the company will repurchase up to 6,400,000 shares for INR 7,200 million. The shares will be repurchased at INR 1,125 per share. The program is subject to approval from shareholders at the postal ballot.お知らせ • Apr 14Cyient Limited to Report Q4, 2026 Results on Apr 23, 2026Cyient Limited announced that they will report Q4, 2026 results at 3:30 PM, Indian Standard Time on Apr 23, 2026Buy Or Sell Opportunity • Apr 02Now 24% overvaluedOver the last 90 days, the stock has fallen 27% to ₹805. The fair value is estimated to be ₹651, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.4% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 24% in 2 years. Earnings are forecast to grow by 50% in the next 2 years.分析記事 • Jan 25Earnings Miss: Cyient Limited Missed EPS By 40% And Analysts Are Revising Their ForecastsThe analysts might have been a bit too bullish on Cyient Limited ( NSE:CYIENT ), given that the company fell short of...お知らせ • Jan 23Cyient Limited Announces Resignation of Matangi Gowrishankar as Independent Director, Chairperson of Leadership, Nomination and Remuneration Committee and from Boards of Cyient Inc. and Cyient Europe Limited, Effective January 22, 2026Cyient Limited announced that Ms. Matangi Gowrishankar (DIN: 01518137), has tendered her resignation as an Independent Director of the Company, effective 22 January 2026. Consequently, she will cease to be Chairperson of Leadership, Nomination and Remuneration Committee of the Company and also step down from the Boards of Cyient Inc. and Cyient Europe Limited which are material subsidiaries of the company. Reconstitution of Leadership, Nomination and Remuneration Committee: Madan Mohan Pillutla Independent Director: Chairperson. MM Murugappan Non- Executive, Non-Independent Director: Member. Nitin Prasad Independent Director: Member. Debjani Ghosh Independent Director: Member.Reported Earnings • Jan 23Third quarter 2026 earnings: EPS and revenues miss analyst expectationsThird quarter 2026 results: EPS: ₹8.32 (down from ₹11.11 in 3Q 2025). Revenue: ₹18.5b (down 4.0% from 3Q 2025). Net income: ₹918.0m (down 25% from 3Q 2025). Profit margin: 5.0% (down from 6.3% in 3Q 2025). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 2.9%. Earnings per share (EPS) also missed analyst estimates by 40%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 7.2% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 8% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • Jan 17Cyient Limited (NSE:CYIENT) Not Flying Under The RadarThere wouldn't be many who think Cyient Limited's ( NSE:CYIENT ) price-to-earnings (or "P/E") ratio of 23.1x is worth a...お知らせ • Dec 29Cyient Limited to Report Q3, 2026 Results on Jan 22, 2026Cyient Limited announced that they will report Q3, 2026 results on Jan 22, 2026分析記事 • Nov 04Returns On Capital At Cyient (NSE:CYIENT) Have StalledIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Reported Earnings • Oct 17Second quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2026 results: EPS: ₹11.55 (down from ₹16.28 in 2Q 2025). Revenue: ₹18.3b (down 1.0% from 2Q 2025). Net income: ₹1.28b (down 29% from 2Q 2025). Profit margin: 7.0% (down from 9.7% in 2Q 2025). Revenue exceeded analyst estimates by 3.1%. Earnings per share (EPS) missed analyst estimates by 15%. Revenue is forecast to grow 9.5% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • Oct 16Is Cyient Limited (NSE:CYIENT) Expensive For A Reason? A Look At Its Intrinsic ValueKey Insights Using the 2 Stage Free Cash Flow to Equity, Cyient fair value estimate is ₹859 Cyient is estimated to be...お知らせ • Oct 01Cyient Limited to Report Q2, 2026 Results on Oct 16, 2025Cyient Limited announced that they will report Q2, 2026 results on Oct 16, 2025分析記事 • Sep 12Earnings Working Against Cyient Limited's (NSE:CYIENT) Share PriceWith a price-to-earnings (or "P/E") ratio of 21.7x Cyient Limited ( NSE:CYIENT ) may be sending bullish signals at the...Board Change • Sep 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Prathivadibhayankara Ramesh was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.分析記事 • Aug 21Here's Why Cyient (NSE:CYIENT) Can Manage Its Debt ResponsiblyNSEI:CYIENT 1 Year Share Price vs Fair Value Explore Cyient's Fair Values from the Community and select yours Some say...お知らせ • Aug 19Cyient Limited Announces Board AppointmentsCyient Limited announced the appointment of eminent business leaders Mr. P. R. Ramesh and Dr. Madan Pillutla to its Board as Independent Directors. With over 40 years of experience, Ramesh is the former Chairman of Deloitte India and a former member of the Deloitte Global Board. A Fellow Member of the Institute of Chartered Accountants of India (ICAI), he has been actively associated with several regulatory and industry bodies, including SEBI, RBI, IRDA, and the Government of India committees on corporate governance and accounting standards. He has also served as the President of the Bombay Chamber of Commerce & Industry in the past. Mr. Ramesh currently also serves on the Boards of leading companies such as Air India, Cipla, L&T, Nestlé India, Crompton Greaves Consumer Electricals, and ITC Hotels. Dr. Pillutla currently serves as Dean & Professor of Organizational Behaviour at the Indian School of Business. He was previously with the London Business School for 22 years, where he held leadership roles including Deputy Dean of Faculty and Member of the Governing Body. His research has been published in leading academic journals, and he has served on editorial boards such as the Administrative Science Quarterly and the Academy of Management Journal. He has also designed and led executive education programs on leadership, negotiation, and influence.Price Target Changed • Jul 30Price target decreased by 7.8% to ₹1,309Down from ₹1,420, the current price target is an average from 21 analysts. New target price is 6.9% above last closing price of ₹1,224. Stock is down 30% over the past year. The company is forecast to post earnings per share of ₹59.64 for next year compared to ₹55.95 last year.分析記事 • Jul 27Analysts Are Updating Their Cyient Limited (NSE:CYIENT) Estimates After Its First-Quarter ResultsCyient Limited ( NSE:CYIENT ) shareholders are probably feeling a little disappointed, since its shares fell 2.8% to...Reported Earnings • Jul 26First quarter 2026 earnings released: EPS: ₹13.95 (vs ₹13.09 in 1Q 2025)First quarter 2026 results: EPS: ₹13.95 (up from ₹13.09 in 1Q 2025). Revenue: ₹17.1b (up 2.2% from 1Q 2025). Net income: ₹1.54b (up 6.9% from 1Q 2025). Profit margin: 9.0% (up from 8.6% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jul 07Cyient Limited to Report Q1, 2026 Results on Jul 24, 2025Cyient Limited announced that they will report Q1, 2026 results on Jul 24, 2025分析記事 • Jul 01Cyient (NSE:CYIENT) Will Pay A Dividend Of ₹14.00Cyient Limited ( NSE:CYIENT ) will pay a dividend of ₹14.00 on the 15th of August. The dividend yield of 2.0% is still...Declared Dividend • Jun 30Final dividend reduced to ₹14.00Dividend of ₹14.00 is 22% lower than last year. Ex-date: 4th July 2025 Payment date: 15th August 2025 Dividend yield will be 2.0%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has increased by an average of 18% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 47% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Jun 26Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: ₹55.95 (down from ₹62.24 in FY 2024). Revenue: ₹73.6b (up 3.0% from FY 2024). Net income: ₹6.16b (down 9.8% from FY 2024). Profit margin: 8.4% (down from 9.6% in FY 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) also missed analyst estimates by 2.5%. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jun 25Cyient Limited, Annual General Meeting, Jul 16, 2025Cyient Limited, Annual General Meeting, Jul 16, 2025, at 15:00 Indian Standard Time.分析記事 • May 01Cyient Limited's (NSE:CYIENT) Business And Shares Still Trailing The MarketWith a price-to-earnings (or "P/E") ratio of 21.4x Cyient Limited ( NSE:CYIENT ) may be sending bullish signals at the...Price Target Changed • Apr 26Price target decreased by 10% to ₹1,446Down from ₹1,608, the current price target is an average from 23 analysts. New target price is 24% above last closing price of ₹1,171. Stock is down 38% over the past year. The company is forecast to post earnings per share of ₹65.17 for next year compared to ₹55.95 last year.Reported Earnings • Apr 25Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: ₹55.95 (down from ₹62.24 in FY 2024). Revenue: ₹73.6b (up 3.0% from FY 2024). Net income: ₹6.16b (down 9.8% from FY 2024). Profit margin: 8.4% (down from 9.6% in FY 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) also missed analyst estimates by 2.5%. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 10% per year and the company’s share price has also increased by 10% per year.お知らせ • Apr 24Cyient Limited Recommends Final Dividend for the Financial Year 2024 - 2025Cyient Limited informed that the Board of Directors of the Company has recommended Final Dividend of INR 14/- per equity share (i.e. 280%) on par value of INR 5/- per share for the financial year 2024 - 2025.分析記事 • Apr 18Should You Think About Buying Cyient Limited (NSE:CYIENT) Now?While Cyient Limited ( NSE:CYIENT ) might not have the largest market cap around , it received a lot of attention from...お知らせ • Apr 08Cyient Limited Appoints Suman Narayan as the CEO of Cyient SemiconductorsCyient Limited announced that have appointed Suman Narayan as the CEO of Cyient Semiconductors. Suman is an accomplished professional in the semiconductor space with a proven track record of managing large organizations, scaling semiconductor businesses, and driving digital transformation. His expertise in semiconductor products and ASIC development will be instrumental in shaping the future of Cyient Semiconductors.分析記事 • Mar 18Is Cyient Limited (NSE:CYIENT) Worth ₹1.2k Based On Its Intrinsic Value?Key Insights Cyient's estimated fair value is ₹905 based on 2 Stage Free Cash Flow to Equity Cyient is estimated to be...お知らせ • Mar 16Cyient Limited Approves Appointment of Ms. Debjani Ghosh as Non-Executive Independent DirectorCyient Limited announced that the at its postal ballot, shareholders approved the appointment of Ms. Debjani Ghosh as Non-Executive Independent Director.お知らせ • Mar 10Cyient Limited Announces Executive ChangesCyient Limited announced that Mr. K.A. Prabhakaran has been appointed as Senior Vice President and Chief Technology Officer of the Company in place of Mr. Rajaneesh Kini effective March 10, 2025. Prabhakaran is an accomplished professional in the engineering & research and development sector with over 30 years of experience. He is an engineering leader who has successfully driven digital transformations, product and process technology innovations building global partnerships with research and academic institutions. He has led large global teams in different industries, such as Aerospace, Oil & Gas, Life Sciences, and Renewable Energy verticals, developing new products and solutions creating organic growth pathways. His expertise is building technology solutions for large OEMs in areas like avionics.お知らせ • Feb 19Cyient Limited Appoints Sukamal Banerjee as Executive Director and Chief Executive Officer of its DET BusinessCyient Limited announced the appointment of Sukamal Banerjee as Executive Director and Chief Executive Officer of its DET business, effective February 19, 2025. He will also serve on the Board of Directors of the company. Sukamal is an accomplished professional and an acknowledged leader in the ER&D and Technology sector with over 30 years of experience. He spent most of his career in HCL Technologies, culminating in the role of Corporate Vice President responsible for engineering business. Most recently, Sukamal was the CEO and Member of the Board of Xoriant. Sukamal has established and grown business lines and created market-leading business partnerships for global accounts with an engineering and technology focus. These include areas like Digital Industry 4.0, and AI/ML across sectors spanning Communications, Semiconductor, Energy, and Transportation, Automotive & Mobility, and Healthcare & Life Sciences, which align well with Cyient's major customer segments. Sukamal brings thought leadership in transitioning industries across technological changes and building global capabilities across geographies.分析記事 • Feb 08Cyient (NSE:CYIENT) Has A Pretty Healthy Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Buy Or Sell Opportunity • Jan 31Now 25% overvaluedOver the last 90 days, the stock has fallen 21% to ₹1,454. The fair value is estimated to be ₹1,160, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 12%. For the next 3 years, revenue is forecast to grow by 11% per annum. Earnings are also forecast to grow by 19% per annum over the same time period.Valuation Update With 7 Day Price Move • Jan 30Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₹1,363, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 27x in the IT industry in India. Total returns to shareholders of 51% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,028 per share.分析記事 • Jan 27Cyient Limited (NSE:CYIENT) Stock's 30% Dive Might Signal An Opportunity But It Requires Some ScrutinyCyient Limited ( NSE:CYIENT ) shares have had a horrible month, losing 30% after a relatively good period beforehand...New Risk • Jan 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.8% average weekly change).Price Target Changed • Jan 24Price target decreased by 11% to ₹1,839Down from ₹2,059, the current price target is an average from 22 analysts. New target price is 37% above last closing price of ₹1,345. Stock is down 33% over the past year. The company is forecast to post earnings per share of ₹57.74 for next year compared to ₹62.24 last year.お知らせ • Jan 23+ 1 more updateCyient Limited Announces Resignation of Karthikeyan Natarajan as Chief Executive OfficerCyient Limited announced that Mr. Karthikeyan Natarajan, (DIN 03099771) has resigned as Chief Executive Officer of the Company on 23 January 2025 to explore new challenges and opportunities.分析記事 • Jan 14What Does Cyient Limited's (NSE:CYIENT) Share Price Indicate?Cyient Limited ( NSE:CYIENT ), is not the largest company out there, but it received a lot of attention from a...分析記事 • Nov 29Here's What To Make Of Cyient's (NSE:CYIENT) Decelerating Rates Of ReturnFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...分析記事 • Oct 27Cyient Limited (NSE:CYIENT) Just Beat EPS By 8.2%: Here's What Analysts Are Forecasting For This YearCyient Limited ( NSE:CYIENT ) investors will be delighted, with the company turning in some strong numbers with its...Declared Dividend • Oct 26First half dividend of ₹12.00 announcedDividend of ₹12.00 is the same as last year. Ex-date: 6th November 2024 Payment date: 23rd November 2024 Dividend yield will be 1.7%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by both earnings (50% earnings payout ratio) and cash flows (52% cash payout ratio). The dividend has increased by an average of 20% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 62% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Oct 25Second quarter 2025 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2025 results: EPS: ₹16.28 (up from ₹16.27 in 2Q 2024). Revenue: ₹18.5b (up 4.0% from 2Q 2024). Net income: ₹1.79b (flat on 2Q 2024). Profit margin: 9.7% (in line with 2Q 2024). Revenue exceeded analyst estimates by 8.8%. Earnings per share (EPS) also surpassed analyst estimates by 8.2%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 19% per year.お知らせ • Oct 24Cyient Limited Declares Interim Dividend for the Financial Year 2024-25, Payable by 21 November 2024by 21 November 2024 informed that the Board of Directors of the Company has declared an Interim Dividend of INR 12 per equity share (240%) on par value of INR 5 per share for the financial year 2024-25. Further, this is to inform that 6 November 2024 is fixed as the record date for the above purpose and the dividend will be paid by 21 November 2024.Buy Or Sell Opportunity • Oct 24Now 22% overvaluedThe stock has been flat over the last 90 days, currently trading at ₹1,778. The fair value is estimated to be ₹1,453, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 11% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.分析記事 • Oct 22Here's Why We Think Cyient (NSE:CYIENT) Is Well Worth WatchingFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...分析記事 • Oct 08Is There Now An Opportunity In Cyient Limited (NSE:CYIENT)?Cyient Limited ( NSE:CYIENT ), is not the largest company out there, but it saw a decent share price growth of 11% on...Recent Insider Transactions • Sep 16CEO & Executive Director recently sold ₹10m worth of stockOn the 9th of September, Karthikeyan Natarajan sold around 5k shares on-market at roughly ₹2,031 per share. This transaction amounted to 4.5% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Karthikeyan has been a net seller over the last 12 months, reducing personal holdings by ₹107m.分析記事 • Sep 13Investors Appear Satisfied With Cyient Limited's (NSE:CYIENT) Prospects As Shares Rocket 27%Cyient Limited ( NSE:CYIENT ) shareholders would be excited to see that the share price has had a great month, posting...Recent Insider Transactions • Sep 08Insider recently sold ₹10m worth of stockOn the 2nd of September, Ajay Aggarwal sold around 5k shares on-market at roughly ₹2,010 per share. This transaction amounted to 25% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹294m more than they bought in the last 12 months.Recent Insider Transactions • Sep 04President & CFO recently sold ₹10m worth of stockOn the 27th of August, Prabhakar Atla sold around 5k shares on-market at roughly ₹2,009 per share. This transaction amounted to 30% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth ₹29m. Prabhakar has been a net seller over the last 12 months, reducing personal holdings by ₹19m.Valuation Update With 7 Day Price Move • Aug 20Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,935, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 31x in the IT industry in India. Total returns to shareholders of 118% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,460 per share.分析記事 • Aug 19Cyient (NSE:CYIENT) Seems To Use Debt Rather SparinglySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Buy Or Sell Opportunity • Aug 14Now 22% overvaluedOver the last 90 days, the stock has fallen 1.7% to ₹1,735. The fair value is estimated to be ₹1,426, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 11% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.分析記事 • Jul 28Cyient Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting NowCyient Limited ( NSE:CYIENT ) just released its latest first-quarter report and things are not looking great. It wasn't...Price Target Changed • Jul 27Price target decreased by 8.8% to ₹1,971Down from ₹2,161, the current price target is an average from 19 analysts. New target price is 10% above last closing price of ₹1,790. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₹65.85 for next year compared to ₹62.24 last year.Reported Earnings • Jul 26First quarter 2025 earnings: EPS and revenues miss analyst expectationsFirst quarter 2025 results: EPS: ₹13.09 (down from ₹15.35 in 1Q 2024). Revenue: ₹17.0b (flat on 1Q 2024). Net income: ₹1.44b (down 14% from 1Q 2024). Profit margin: 8.5% (down from 10.0% in 1Q 2024). Revenue missed analyst estimates by 3.3%. Earnings per share (EPS) also missed analyst estimates by 23%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 22% per year.分析記事 • Jul 25Cyient (NSE:CYIENT) Has More To Do To Multiply In Value Going ForwardWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...分析記事 • Jul 12Are Cyient Limited (NSE:CYIENT) Investors Paying Above The Intrinsic Value?Key Insights Cyient's estimated fair value is ₹1,394 based on 2 Stage Free Cash Flow to Equity Cyient's ₹1,773 share...お知らせ • Jul 01Cyient Limited Approves Final Dividend for the Financial Year 2023-2024Cyient Limited at its AGM held on July 01, 2024, approved to confirm the payment of interim dividend of INR 12/- on the equity shares and to declare a final dividend of INR 18/- on the equity shares for the financial year 2023-24.分析記事 • Jun 26Cyient Limited's (NSE:CYIENT) Shares May Have Run Too Fast Too SoonWith a median price-to-earnings (or "P/E") ratio of close to 32x in India, you could be forgiven for feeling...分析記事 • Jun 14Cyient (NSE:CYIENT) Has Announced That It Will Be Increasing Its Dividend To ₹18.00Cyient Limited ( NSE:CYIENT ) will increase its dividend from last year's comparable payment on the 31st of July to...Recent Insider Transactions • Jun 13CEO & Executive Director recently sold ₹29m worth of stockOn the 7th of June, Karthikeyan Natarajan sold around 15k shares on-market at roughly ₹1,921 per share. This transaction amounted to 13% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Karthikeyan has been a net seller over the last 12 months, reducing personal holdings by ₹108m.Declared Dividend • Jun 13Final dividend increased to ₹18.00Dividend of ₹18.00 is 13% higher than last year. Ex-date: 21st June 2024 Payment date: 31st July 2024 Dividend yield will be 1.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by both earnings (48% earnings payout ratio) and cash flows (52% cash payout ratio). The dividend has increased by an average of 20% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 54% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Jun 10+ 4 more updatesCyient Limited, Annual General Meeting, Jul 01, 2024Cyient Limited, Annual General Meeting, Jul 01, 2024, at 14:30 Indian Standard Time.分析記事 • Jun 04Here's Why Cyient (NSE:CYIENT) Has Caught The Eye Of InvestorsInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Board Change • May 31Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Nitin Prasad was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Apr 27Full year 2024 earnings: EPS misses analyst expectationsFull year 2024 results: EPS: ₹62.24 (up from ₹47.04 in FY 2023). Revenue: ₹71.5b (up 19% from FY 2023). Net income: ₹6.83b (up 33% from FY 2023). Profit margin: 9.6% (up from 8.5% in FY 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 5.9%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Apr 26Cyient Limited Recommends Final Dividend for the Financial Year 2023-2024The Board of Directors of Cyient Limited have recommended a Final Dividend of INR 18/- (i.e 360%) per equity share on face value of INR 5/- per share, for the financial year 2023-24.分析記事 • Apr 18What Does Cyient Limited's (NSE:CYIENT) Share Price Indicate?Cyient Limited ( NSE:CYIENT ), is not the largest company out there, but it saw significant share price movement during...お知らせ • Apr 12Cyient Limited to Report Q4, 2024 Results on Apr 25, 2024Cyient Limited announced that they will report Q4, 2024 results on Apr 25, 2024分析記事 • Mar 19Cyient (NSE:CYIENT) Is Reinvesting To Multiply In ValueDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...分析記事 • Mar 04Is Cyient (NSE:CYIENT) A Risky Investment?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...分析記事 • Jan 28Cyient Limited Just Missed Earnings - But Analysts Have Updated Their ModelsShareholders might have noticed that Cyient Limited ( NSE:CYIENT ) filed its quarterly result this time last week. The...Reported Earnings • Jan 26Third quarter 2024 earnings: EPS misses analyst expectationsThird quarter 2024 results: EPS: ₹13.41 (down from ₹14.26 in 3Q 2023). Revenue: ₹18.4b (up 14% from 3Q 2023). Net income: ₹1.47b (down 5.6% from 3Q 2023). Profit margin: 8.0% (down from 9.6% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 25%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 8.5% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • Jan 16Is It Too Late To Consider Buying Cyient Limited (NSE:CYIENT)?Cyient Limited ( NSE:CYIENT ), is not the largest company out there, but it led the NSEI gainers with a relatively...Price Target Changed • Jan 10Price target increased by 8.7% to ₹2,201Up from ₹2,025, the current price target is an average from 17 analysts. New target price is approximately in line with last closing price of ₹2,224. Stock is up 162% over the past year. The company is forecast to post earnings per share of ₹67.67 for next year compared to ₹47.03 last year.Recent Insider Transactions • Jan 06Insider recently sold ₹5.8m worth of stockOn the 29th of December, Prabhakar Shetty sold around 3k shares on-market at roughly ₹2,300 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth ₹59m. Insiders have been net sellers, collectively disposing of ₹531m more than they bought in the last 12 months.分析記事 • Jan 04If EPS Growth Is Important To You, Cyient (NSE:CYIENT) Presents An OpportunityFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...財務状況分析短期負債: CYIENTの 短期資産 ( ₹46.7B ) が 短期負債 ( ₹15.9B ) を超えています。長期負債: CYIENTの短期資産 ( ₹46.7B ) が 長期負債 ( ₹5.7B ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: CYIENT総負債よりも多くの現金を保有しています。負債の削減: CYIENTの負債対資本比率は、過去 5 年間で10.8%から3.2%に減少しました。債務返済能力: CYIENTの負債は 営業キャッシュフロー によって 十分にカバー されています ( 396.7% )。インタレストカバレッジ: CYIENT支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。貸借対照表健全な企業の発掘7D1Y7D1Y7D1YSoftware 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/14 08:52終値2026/07/14 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Cyient Limited 12 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。45 アナリスト機関Moez ChandaniAmbit CapitalNitin BhasinAmbit CapitalAshwin MehtaAmbit Capital42 その他のアナリストを表示
分析記事 • Aug 21Here's Why Cyient (NSE:CYIENT) Can Manage Its Debt ResponsiblyNSEI:CYIENT 1 Year Share Price vs Fair Value Explore Cyient's Fair Values from the Community and select yours Some say...
分析記事 • Feb 08Cyient (NSE:CYIENT) Has A Pretty Healthy Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
分析記事 • Aug 19Cyient (NSE:CYIENT) Seems To Use Debt Rather SparinglySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
分析記事 • Mar 04Is Cyient (NSE:CYIENT) A Risky Investment?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Buy Or Sell Opportunity • Jul 09Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 8.7% to ₹831. The fair value is estimated to be ₹1,039, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.7% over the last 3 years. Earnings per share has declined by 4.8%. For the next 3 years, revenue is forecast to grow by 11% per annum. Earnings are also forecast to grow by 22% per annum over the same time period.
Reported Earnings • Jun 13Full year 2026 earnings: EPS and revenues miss analyst expectationsFull year 2026 results: EPS: ₹38.78 (down from ₹55.95 in FY 2025). Revenue: ₹72.7b (down 1.3% from FY 2025). Net income: ₹4.28b (down 31% from FY 2025). Profit margin: 5.9% (down from 8.4% in FY 2025). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) also missed analyst estimates by 27%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings.
お知らせ • Jun 10+ 5 more updatesCyient Limited Proposes Not to Pay Final Dividend for the Year Ended on March 31, 2026Cyient Limited proposed Final dividend for the year ended on March 31, 2026: Nil (March 31, 2025: INR 14 per share).
お知らせ • Jun 01Cyient Limited (BSE:532175) agreed to acquire Tao Digital Solutions Inc.Cyient Limited (BSE:532175) agreed to acquire Tao Digital Solutions Inc. on May 30, 2026. The transaction implies an enterprise value of $218 million, excluding management incentives, and retention schemes. The nature of consideration is in cash, including upfront payment and performance-linked earnout. For the period ending December 31, 2025, Tao Digital Solutions Inc. reported total revenue of $79.1 million. The transaction is subject to approval by regulatory board / committee. The expected completion of the transaction is on or before September 30, 2026.
分析記事 • May 01Cyient's (NSE:CYIENT) Soft Earnings Are Actually Better Than They AppearInvestors were disappointed with the weak earnings posted by Cyient Limited ( NSE:CYIENT ). However, our analysis...
Reported Earnings • Apr 29Full year 2026 earnings: EPS and revenues miss analyst expectationsFull year 2026 results: EPS: ₹38.78 (down from ₹55.95 in FY 2025). Revenue: ₹72.7b (down 1.3% from FY 2025). Net income: ₹4.28b (down 31% from FY 2025). Profit margin: 5.9% (down from 8.4% in FY 2025). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) also missed analyst estimates by 27%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 10% per year.
お知らせ • Apr 24Cyient Limited (BSE:532175) announces an Equity Buyback for 6,400,000 shares, for INR 7,200 million.Cyient Limited (BSE:532175) announces a share repurchase program. Under the program, the company will repurchase up to 6,400,000 shares for INR 7,200 million. The shares will be repurchased at INR 1,125 per share. The program is subject to approval from shareholders at the postal ballot.
お知らせ • Apr 14Cyient Limited to Report Q4, 2026 Results on Apr 23, 2026Cyient Limited announced that they will report Q4, 2026 results at 3:30 PM, Indian Standard Time on Apr 23, 2026
Buy Or Sell Opportunity • Apr 02Now 24% overvaluedOver the last 90 days, the stock has fallen 27% to ₹805. The fair value is estimated to be ₹651, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.4% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 24% in 2 years. Earnings are forecast to grow by 50% in the next 2 years.
分析記事 • Jan 25Earnings Miss: Cyient Limited Missed EPS By 40% And Analysts Are Revising Their ForecastsThe analysts might have been a bit too bullish on Cyient Limited ( NSE:CYIENT ), given that the company fell short of...
お知らせ • Jan 23Cyient Limited Announces Resignation of Matangi Gowrishankar as Independent Director, Chairperson of Leadership, Nomination and Remuneration Committee and from Boards of Cyient Inc. and Cyient Europe Limited, Effective January 22, 2026Cyient Limited announced that Ms. Matangi Gowrishankar (DIN: 01518137), has tendered her resignation as an Independent Director of the Company, effective 22 January 2026. Consequently, she will cease to be Chairperson of Leadership, Nomination and Remuneration Committee of the Company and also step down from the Boards of Cyient Inc. and Cyient Europe Limited which are material subsidiaries of the company. Reconstitution of Leadership, Nomination and Remuneration Committee: Madan Mohan Pillutla Independent Director: Chairperson. MM Murugappan Non- Executive, Non-Independent Director: Member. Nitin Prasad Independent Director: Member. Debjani Ghosh Independent Director: Member.
Reported Earnings • Jan 23Third quarter 2026 earnings: EPS and revenues miss analyst expectationsThird quarter 2026 results: EPS: ₹8.32 (down from ₹11.11 in 3Q 2025). Revenue: ₹18.5b (down 4.0% from 3Q 2025). Net income: ₹918.0m (down 25% from 3Q 2025). Profit margin: 5.0% (down from 6.3% in 3Q 2025). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 2.9%. Earnings per share (EPS) also missed analyst estimates by 40%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 7.2% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 8% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • Jan 17Cyient Limited (NSE:CYIENT) Not Flying Under The RadarThere wouldn't be many who think Cyient Limited's ( NSE:CYIENT ) price-to-earnings (or "P/E") ratio of 23.1x is worth a...
お知らせ • Dec 29Cyient Limited to Report Q3, 2026 Results on Jan 22, 2026Cyient Limited announced that they will report Q3, 2026 results on Jan 22, 2026
分析記事 • Nov 04Returns On Capital At Cyient (NSE:CYIENT) Have StalledIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Reported Earnings • Oct 17Second quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2026 results: EPS: ₹11.55 (down from ₹16.28 in 2Q 2025). Revenue: ₹18.3b (down 1.0% from 2Q 2025). Net income: ₹1.28b (down 29% from 2Q 2025). Profit margin: 7.0% (down from 9.7% in 2Q 2025). Revenue exceeded analyst estimates by 3.1%. Earnings per share (EPS) missed analyst estimates by 15%. Revenue is forecast to grow 9.5% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • Oct 16Is Cyient Limited (NSE:CYIENT) Expensive For A Reason? A Look At Its Intrinsic ValueKey Insights Using the 2 Stage Free Cash Flow to Equity, Cyient fair value estimate is ₹859 Cyient is estimated to be...
お知らせ • Oct 01Cyient Limited to Report Q2, 2026 Results on Oct 16, 2025Cyient Limited announced that they will report Q2, 2026 results on Oct 16, 2025
分析記事 • Sep 12Earnings Working Against Cyient Limited's (NSE:CYIENT) Share PriceWith a price-to-earnings (or "P/E") ratio of 21.7x Cyient Limited ( NSE:CYIENT ) may be sending bullish signals at the...
Board Change • Sep 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Prathivadibhayankara Ramesh was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
分析記事 • Aug 21Here's Why Cyient (NSE:CYIENT) Can Manage Its Debt ResponsiblyNSEI:CYIENT 1 Year Share Price vs Fair Value Explore Cyient's Fair Values from the Community and select yours Some say...
お知らせ • Aug 19Cyient Limited Announces Board AppointmentsCyient Limited announced the appointment of eminent business leaders Mr. P. R. Ramesh and Dr. Madan Pillutla to its Board as Independent Directors. With over 40 years of experience, Ramesh is the former Chairman of Deloitte India and a former member of the Deloitte Global Board. A Fellow Member of the Institute of Chartered Accountants of India (ICAI), he has been actively associated with several regulatory and industry bodies, including SEBI, RBI, IRDA, and the Government of India committees on corporate governance and accounting standards. He has also served as the President of the Bombay Chamber of Commerce & Industry in the past. Mr. Ramesh currently also serves on the Boards of leading companies such as Air India, Cipla, L&T, Nestlé India, Crompton Greaves Consumer Electricals, and ITC Hotels. Dr. Pillutla currently serves as Dean & Professor of Organizational Behaviour at the Indian School of Business. He was previously with the London Business School for 22 years, where he held leadership roles including Deputy Dean of Faculty and Member of the Governing Body. His research has been published in leading academic journals, and he has served on editorial boards such as the Administrative Science Quarterly and the Academy of Management Journal. He has also designed and led executive education programs on leadership, negotiation, and influence.
Price Target Changed • Jul 30Price target decreased by 7.8% to ₹1,309Down from ₹1,420, the current price target is an average from 21 analysts. New target price is 6.9% above last closing price of ₹1,224. Stock is down 30% over the past year. The company is forecast to post earnings per share of ₹59.64 for next year compared to ₹55.95 last year.
分析記事 • Jul 27Analysts Are Updating Their Cyient Limited (NSE:CYIENT) Estimates After Its First-Quarter ResultsCyient Limited ( NSE:CYIENT ) shareholders are probably feeling a little disappointed, since its shares fell 2.8% to...
Reported Earnings • Jul 26First quarter 2026 earnings released: EPS: ₹13.95 (vs ₹13.09 in 1Q 2025)First quarter 2026 results: EPS: ₹13.95 (up from ₹13.09 in 1Q 2025). Revenue: ₹17.1b (up 2.2% from 1Q 2025). Net income: ₹1.54b (up 6.9% from 1Q 2025). Profit margin: 9.0% (up from 8.6% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jul 07Cyient Limited to Report Q1, 2026 Results on Jul 24, 2025Cyient Limited announced that they will report Q1, 2026 results on Jul 24, 2025
分析記事 • Jul 01Cyient (NSE:CYIENT) Will Pay A Dividend Of ₹14.00Cyient Limited ( NSE:CYIENT ) will pay a dividend of ₹14.00 on the 15th of August. The dividend yield of 2.0% is still...
Declared Dividend • Jun 30Final dividend reduced to ₹14.00Dividend of ₹14.00 is 22% lower than last year. Ex-date: 4th July 2025 Payment date: 15th August 2025 Dividend yield will be 2.0%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has increased by an average of 18% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 47% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Jun 26Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: ₹55.95 (down from ₹62.24 in FY 2024). Revenue: ₹73.6b (up 3.0% from FY 2024). Net income: ₹6.16b (down 9.8% from FY 2024). Profit margin: 8.4% (down from 9.6% in FY 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) also missed analyst estimates by 2.5%. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 20% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jun 25Cyient Limited, Annual General Meeting, Jul 16, 2025Cyient Limited, Annual General Meeting, Jul 16, 2025, at 15:00 Indian Standard Time.
分析記事 • May 01Cyient Limited's (NSE:CYIENT) Business And Shares Still Trailing The MarketWith a price-to-earnings (or "P/E") ratio of 21.4x Cyient Limited ( NSE:CYIENT ) may be sending bullish signals at the...
Price Target Changed • Apr 26Price target decreased by 10% to ₹1,446Down from ₹1,608, the current price target is an average from 23 analysts. New target price is 24% above last closing price of ₹1,171. Stock is down 38% over the past year. The company is forecast to post earnings per share of ₹65.17 for next year compared to ₹55.95 last year.
Reported Earnings • Apr 25Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: ₹55.95 (down from ₹62.24 in FY 2024). Revenue: ₹73.6b (up 3.0% from FY 2024). Net income: ₹6.16b (down 9.8% from FY 2024). Profit margin: 8.4% (down from 9.6% in FY 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) also missed analyst estimates by 2.5%. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 10% per year and the company’s share price has also increased by 10% per year.
お知らせ • Apr 24Cyient Limited Recommends Final Dividend for the Financial Year 2024 - 2025Cyient Limited informed that the Board of Directors of the Company has recommended Final Dividend of INR 14/- per equity share (i.e. 280%) on par value of INR 5/- per share for the financial year 2024 - 2025.
分析記事 • Apr 18Should You Think About Buying Cyient Limited (NSE:CYIENT) Now?While Cyient Limited ( NSE:CYIENT ) might not have the largest market cap around , it received a lot of attention from...
お知らせ • Apr 08Cyient Limited Appoints Suman Narayan as the CEO of Cyient SemiconductorsCyient Limited announced that have appointed Suman Narayan as the CEO of Cyient Semiconductors. Suman is an accomplished professional in the semiconductor space with a proven track record of managing large organizations, scaling semiconductor businesses, and driving digital transformation. His expertise in semiconductor products and ASIC development will be instrumental in shaping the future of Cyient Semiconductors.
分析記事 • Mar 18Is Cyient Limited (NSE:CYIENT) Worth ₹1.2k Based On Its Intrinsic Value?Key Insights Cyient's estimated fair value is ₹905 based on 2 Stage Free Cash Flow to Equity Cyient is estimated to be...
お知らせ • Mar 16Cyient Limited Approves Appointment of Ms. Debjani Ghosh as Non-Executive Independent DirectorCyient Limited announced that the at its postal ballot, shareholders approved the appointment of Ms. Debjani Ghosh as Non-Executive Independent Director.
お知らせ • Mar 10Cyient Limited Announces Executive ChangesCyient Limited announced that Mr. K.A. Prabhakaran has been appointed as Senior Vice President and Chief Technology Officer of the Company in place of Mr. Rajaneesh Kini effective March 10, 2025. Prabhakaran is an accomplished professional in the engineering & research and development sector with over 30 years of experience. He is an engineering leader who has successfully driven digital transformations, product and process technology innovations building global partnerships with research and academic institutions. He has led large global teams in different industries, such as Aerospace, Oil & Gas, Life Sciences, and Renewable Energy verticals, developing new products and solutions creating organic growth pathways. His expertise is building technology solutions for large OEMs in areas like avionics.
お知らせ • Feb 19Cyient Limited Appoints Sukamal Banerjee as Executive Director and Chief Executive Officer of its DET BusinessCyient Limited announced the appointment of Sukamal Banerjee as Executive Director and Chief Executive Officer of its DET business, effective February 19, 2025. He will also serve on the Board of Directors of the company. Sukamal is an accomplished professional and an acknowledged leader in the ER&D and Technology sector with over 30 years of experience. He spent most of his career in HCL Technologies, culminating in the role of Corporate Vice President responsible for engineering business. Most recently, Sukamal was the CEO and Member of the Board of Xoriant. Sukamal has established and grown business lines and created market-leading business partnerships for global accounts with an engineering and technology focus. These include areas like Digital Industry 4.0, and AI/ML across sectors spanning Communications, Semiconductor, Energy, and Transportation, Automotive & Mobility, and Healthcare & Life Sciences, which align well with Cyient's major customer segments. Sukamal brings thought leadership in transitioning industries across technological changes and building global capabilities across geographies.
分析記事 • Feb 08Cyient (NSE:CYIENT) Has A Pretty Healthy Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Buy Or Sell Opportunity • Jan 31Now 25% overvaluedOver the last 90 days, the stock has fallen 21% to ₹1,454. The fair value is estimated to be ₹1,160, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 12%. For the next 3 years, revenue is forecast to grow by 11% per annum. Earnings are also forecast to grow by 19% per annum over the same time period.
Valuation Update With 7 Day Price Move • Jan 30Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₹1,363, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 27x in the IT industry in India. Total returns to shareholders of 51% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,028 per share.
分析記事 • Jan 27Cyient Limited (NSE:CYIENT) Stock's 30% Dive Might Signal An Opportunity But It Requires Some ScrutinyCyient Limited ( NSE:CYIENT ) shares have had a horrible month, losing 30% after a relatively good period beforehand...
New Risk • Jan 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.8% average weekly change).
Price Target Changed • Jan 24Price target decreased by 11% to ₹1,839Down from ₹2,059, the current price target is an average from 22 analysts. New target price is 37% above last closing price of ₹1,345. Stock is down 33% over the past year. The company is forecast to post earnings per share of ₹57.74 for next year compared to ₹62.24 last year.
お知らせ • Jan 23+ 1 more updateCyient Limited Announces Resignation of Karthikeyan Natarajan as Chief Executive OfficerCyient Limited announced that Mr. Karthikeyan Natarajan, (DIN 03099771) has resigned as Chief Executive Officer of the Company on 23 January 2025 to explore new challenges and opportunities.
分析記事 • Jan 14What Does Cyient Limited's (NSE:CYIENT) Share Price Indicate?Cyient Limited ( NSE:CYIENT ), is not the largest company out there, but it received a lot of attention from a...
分析記事 • Nov 29Here's What To Make Of Cyient's (NSE:CYIENT) Decelerating Rates Of ReturnFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
分析記事 • Oct 27Cyient Limited (NSE:CYIENT) Just Beat EPS By 8.2%: Here's What Analysts Are Forecasting For This YearCyient Limited ( NSE:CYIENT ) investors will be delighted, with the company turning in some strong numbers with its...
Declared Dividend • Oct 26First half dividend of ₹12.00 announcedDividend of ₹12.00 is the same as last year. Ex-date: 6th November 2024 Payment date: 23rd November 2024 Dividend yield will be 1.7%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by both earnings (50% earnings payout ratio) and cash flows (52% cash payout ratio). The dividend has increased by an average of 20% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 62% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Oct 25Second quarter 2025 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2025 results: EPS: ₹16.28 (up from ₹16.27 in 2Q 2024). Revenue: ₹18.5b (up 4.0% from 2Q 2024). Net income: ₹1.79b (flat on 2Q 2024). Profit margin: 9.7% (in line with 2Q 2024). Revenue exceeded analyst estimates by 8.8%. Earnings per share (EPS) also surpassed analyst estimates by 8.2%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 19% per year.
お知らせ • Oct 24Cyient Limited Declares Interim Dividend for the Financial Year 2024-25, Payable by 21 November 2024by 21 November 2024 informed that the Board of Directors of the Company has declared an Interim Dividend of INR 12 per equity share (240%) on par value of INR 5 per share for the financial year 2024-25. Further, this is to inform that 6 November 2024 is fixed as the record date for the above purpose and the dividend will be paid by 21 November 2024.
Buy Or Sell Opportunity • Oct 24Now 22% overvaluedThe stock has been flat over the last 90 days, currently trading at ₹1,778. The fair value is estimated to be ₹1,453, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 11% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.
分析記事 • Oct 22Here's Why We Think Cyient (NSE:CYIENT) Is Well Worth WatchingFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
分析記事 • Oct 08Is There Now An Opportunity In Cyient Limited (NSE:CYIENT)?Cyient Limited ( NSE:CYIENT ), is not the largest company out there, but it saw a decent share price growth of 11% on...
Recent Insider Transactions • Sep 16CEO & Executive Director recently sold ₹10m worth of stockOn the 9th of September, Karthikeyan Natarajan sold around 5k shares on-market at roughly ₹2,031 per share. This transaction amounted to 4.5% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Karthikeyan has been a net seller over the last 12 months, reducing personal holdings by ₹107m.
分析記事 • Sep 13Investors Appear Satisfied With Cyient Limited's (NSE:CYIENT) Prospects As Shares Rocket 27%Cyient Limited ( NSE:CYIENT ) shareholders would be excited to see that the share price has had a great month, posting...
Recent Insider Transactions • Sep 08Insider recently sold ₹10m worth of stockOn the 2nd of September, Ajay Aggarwal sold around 5k shares on-market at roughly ₹2,010 per share. This transaction amounted to 25% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹294m more than they bought in the last 12 months.
Recent Insider Transactions • Sep 04President & CFO recently sold ₹10m worth of stockOn the 27th of August, Prabhakar Atla sold around 5k shares on-market at roughly ₹2,009 per share. This transaction amounted to 30% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth ₹29m. Prabhakar has been a net seller over the last 12 months, reducing personal holdings by ₹19m.
Valuation Update With 7 Day Price Move • Aug 20Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,935, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 31x in the IT industry in India. Total returns to shareholders of 118% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹1,460 per share.
分析記事 • Aug 19Cyient (NSE:CYIENT) Seems To Use Debt Rather SparinglySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Buy Or Sell Opportunity • Aug 14Now 22% overvaluedOver the last 90 days, the stock has fallen 1.7% to ₹1,735. The fair value is estimated to be ₹1,426, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has grown by 17%. For the next 3 years, revenue is forecast to grow by 11% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.
分析記事 • Jul 28Cyient Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting NowCyient Limited ( NSE:CYIENT ) just released its latest first-quarter report and things are not looking great. It wasn't...
Price Target Changed • Jul 27Price target decreased by 8.8% to ₹1,971Down from ₹2,161, the current price target is an average from 19 analysts. New target price is 10% above last closing price of ₹1,790. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₹65.85 for next year compared to ₹62.24 last year.
Reported Earnings • Jul 26First quarter 2025 earnings: EPS and revenues miss analyst expectationsFirst quarter 2025 results: EPS: ₹13.09 (down from ₹15.35 in 1Q 2024). Revenue: ₹17.0b (flat on 1Q 2024). Net income: ₹1.44b (down 14% from 1Q 2024). Profit margin: 8.5% (down from 10.0% in 1Q 2024). Revenue missed analyst estimates by 3.3%. Earnings per share (EPS) also missed analyst estimates by 23%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 22% per year.
分析記事 • Jul 25Cyient (NSE:CYIENT) Has More To Do To Multiply In Value Going ForwardWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...
分析記事 • Jul 12Are Cyient Limited (NSE:CYIENT) Investors Paying Above The Intrinsic Value?Key Insights Cyient's estimated fair value is ₹1,394 based on 2 Stage Free Cash Flow to Equity Cyient's ₹1,773 share...
お知らせ • Jul 01Cyient Limited Approves Final Dividend for the Financial Year 2023-2024Cyient Limited at its AGM held on July 01, 2024, approved to confirm the payment of interim dividend of INR 12/- on the equity shares and to declare a final dividend of INR 18/- on the equity shares for the financial year 2023-24.
分析記事 • Jun 26Cyient Limited's (NSE:CYIENT) Shares May Have Run Too Fast Too SoonWith a median price-to-earnings (or "P/E") ratio of close to 32x in India, you could be forgiven for feeling...
分析記事 • Jun 14Cyient (NSE:CYIENT) Has Announced That It Will Be Increasing Its Dividend To ₹18.00Cyient Limited ( NSE:CYIENT ) will increase its dividend from last year's comparable payment on the 31st of July to...
Recent Insider Transactions • Jun 13CEO & Executive Director recently sold ₹29m worth of stockOn the 7th of June, Karthikeyan Natarajan sold around 15k shares on-market at roughly ₹1,921 per share. This transaction amounted to 13% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Karthikeyan has been a net seller over the last 12 months, reducing personal holdings by ₹108m.
Declared Dividend • Jun 13Final dividend increased to ₹18.00Dividend of ₹18.00 is 13% higher than last year. Ex-date: 21st June 2024 Payment date: 31st July 2024 Dividend yield will be 1.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by both earnings (48% earnings payout ratio) and cash flows (52% cash payout ratio). The dividend has increased by an average of 20% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 54% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Jun 10+ 4 more updatesCyient Limited, Annual General Meeting, Jul 01, 2024Cyient Limited, Annual General Meeting, Jul 01, 2024, at 14:30 Indian Standard Time.
分析記事 • Jun 04Here's Why Cyient (NSE:CYIENT) Has Caught The Eye Of InvestorsInvestors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Board Change • May 31Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Nitin Prasad was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Apr 27Full year 2024 earnings: EPS misses analyst expectationsFull year 2024 results: EPS: ₹62.24 (up from ₹47.04 in FY 2023). Revenue: ₹71.5b (up 19% from FY 2023). Net income: ₹6.83b (up 33% from FY 2023). Profit margin: 9.6% (up from 8.5% in FY 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 5.9%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Apr 26Cyient Limited Recommends Final Dividend for the Financial Year 2023-2024The Board of Directors of Cyient Limited have recommended a Final Dividend of INR 18/- (i.e 360%) per equity share on face value of INR 5/- per share, for the financial year 2023-24.
分析記事 • Apr 18What Does Cyient Limited's (NSE:CYIENT) Share Price Indicate?Cyient Limited ( NSE:CYIENT ), is not the largest company out there, but it saw significant share price movement during...
お知らせ • Apr 12Cyient Limited to Report Q4, 2024 Results on Apr 25, 2024Cyient Limited announced that they will report Q4, 2024 results on Apr 25, 2024
分析記事 • Mar 19Cyient (NSE:CYIENT) Is Reinvesting To Multiply In ValueDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...
分析記事 • Mar 04Is Cyient (NSE:CYIENT) A Risky Investment?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
分析記事 • Jan 28Cyient Limited Just Missed Earnings - But Analysts Have Updated Their ModelsShareholders might have noticed that Cyient Limited ( NSE:CYIENT ) filed its quarterly result this time last week. The...
Reported Earnings • Jan 26Third quarter 2024 earnings: EPS misses analyst expectationsThird quarter 2024 results: EPS: ₹13.41 (down from ₹14.26 in 3Q 2023). Revenue: ₹18.4b (up 14% from 3Q 2023). Net income: ₹1.47b (down 5.6% from 3Q 2023). Profit margin: 8.0% (down from 9.6% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 25%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 8.5% growth forecast for the IT industry in India. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • Jan 16Is It Too Late To Consider Buying Cyient Limited (NSE:CYIENT)?Cyient Limited ( NSE:CYIENT ), is not the largest company out there, but it led the NSEI gainers with a relatively...
Price Target Changed • Jan 10Price target increased by 8.7% to ₹2,201Up from ₹2,025, the current price target is an average from 17 analysts. New target price is approximately in line with last closing price of ₹2,224. Stock is up 162% over the past year. The company is forecast to post earnings per share of ₹67.67 for next year compared to ₹47.03 last year.
Recent Insider Transactions • Jan 06Insider recently sold ₹5.8m worth of stockOn the 29th of December, Prabhakar Shetty sold around 3k shares on-market at roughly ₹2,300 per share. This transaction amounted to 100% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth ₹59m. Insiders have been net sellers, collectively disposing of ₹531m more than they bought in the last 12 months.
分析記事 • Jan 04If EPS Growth Is Important To You, Cyient (NSE:CYIENT) Presents An OpportunityFor beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...